Global Hypodermic (Passive & Active) Needle Market, 2022: Market is Expected to Witness the Fastest Growth in Asia-Pacific

Dublin, April 04, 2017 -- Research and Markets has announced the addition of the "Global Hypodermic Needle Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.

The global hypodermic market is expected to grow at a CAGR of 7.4% during 2016 - 2022.

The growing geriatric population, increasing prevalence of chronic and lifestyle associated diseases, increasing demand for vaccines, and increasing compliance for safety needles are the key factors driving the growth of the global market. The innovation for safety from needle stick is the major concern for regulatory bodies, as the number of logged needle stick injuries in healthcare workers is high. Therefore, new regulation in various regions would mandate the complete use of safety hypodermic needle to prevent needle stick injuries. For instance, WHO hosts and coordinates the Safe Injection Global Network (SIGN) to promote and sustain injection safety worldwide.

The safety needles have two modes of activation - passive and active, where passive hypodermic needle led the global safety hypodermic needle market in 2015. The passive hypodermic needle is also expected to witness higher growth during the forecast period due to its several advantages over conventional hypodermic needles. Automatic safety mechanisms and ease of use are the key growth drivers for the global passive hypodermic needle market.

Geographically, North America accounted for the largest hypodermic needle market in 2015 and it is expected to grow at a considerable rate during the forecast period. The factors driving the hypodermic needle market in the region are increasing awareness of safe injectable technology, and increasing prevalence of chronic and lifestyle associated diseases.

Europe was the second largest market for hypodermic needles in 2015.The hypodermic needle market is expected to witness the fastest growth in Asia-Pacific, during the forecast period.

The highest growth in the region is attributed to the improving healthcare infrastructure and increasing awareness regarding safe usage of needle or syringe. China is expected to be the fastest growing market for hypodermic needle globally during the forecast period.

Key Topics Covered:

1. Research Scope And Methodology

2. Executive Summary
2.1 Key Findings
2.2 Research Summary

3. Market Outlook
3.1 Introduction
3.2 Opportunities In The Global Hypodermic Needle Market
3.2.1 Adoption Of Hypodermic Needles In Emerging Markets
3.3 Factors Driving The Growth Of The Market And Its Impact On Market Forecast
3.3.1 Growing Geriatric Population
3.3.2 Increasing Prevalence Of Chronic Diseases And Lifestyle Associated Diseases
3.3.3 Increasing Demand For Vaccines
3.3.4 Increasing Compliance Of Safety Needles
3.3.5 Impact Analysis Of Drivers On Market Forecast
3.4 Factors Hindering Growth Of The Market And Its Impact On Market Forecast
3.4.1 Alternative Drug Delivery Methods
3.4.2 High Cost Of Hypodermic Needles
3.4.3 Impact Analysis Of Restraints On Market Forecast

4. Global Hypodermic Needle Market Size And Forecast (2012 - 2022)
4.1 Global Hypodermic Needle Market, By Type
4.2 Global Hypodermic Needle Market, By End User
4.3 Global Hypodermic Needle Market, By Region

5. Global Hypodermic Needle Market, By Type
5.1 Safety Hypodermic Needle Market
5.1.1 Global Safety Hypodermic Needle Market, By Region
5.1.2 Global Safety Hypodermic Needle Market, By Type
5.1.3 Global Safety Hypodermic Needle Market, By Mode Of Activation
5.2 Non-Safety Hypodermic Needle Market

6. Global Hypodermic Needle Market, By End User
6.1 Hypodermic Needle Market In Hospital
6.2 Hypodermic Needle Market In Diagnostic Center

7. Global Hypodermic Needle Market, By Geography

8. Competitive Analysis

9. Company Profiles And Strategic Developments

• Vygon S.A.
• Catalent Inc.
• Terumo Corporation
• Retractable Technologies Inc.
• Connecticut Hypodermics Inc.
• Medpro Safety Products, Inc
• B. Braun Melsungen Ag
• Albert David Ltd.
• Becton, Dickinson And Company
• Medtronic Plc
  

For more information about this report visit http://www.researchandmarkets.com/research/l2fbsw/global_hypodermic

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Infusions and Injectables , Needles and Syringes